Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Neuronetics Stock

Price
Target price
€1.57

€1.57

0.380%
0.006
0.380%
€7.35
 
02.07.24 / Stuttgart Stock Exchange WKN: A2JPMY / Symbol: STIM / Name: Neuronetics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Neuronetics in the next few years
Wizard

Neuronetics Stock

Neuronetics gained 0.380% compared to yesterday.
The community is currently still undecided about Neuronetics with 2 Buy predictions and 0 Sell predictions.
With a target price of 7 € there is potential for a 344.73% increase which would mean more than doubling the current price of 1.57 € for Neuronetics.
What does Neuronetics do?

Pros and Cons of Neuronetics in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-02

Neuronetics Inc (NASDAQ: STIM) is a company in the healthcare industry focused on developing and commercializing cutting-edge technologies to address various neurological disorders. At a glance, the financial statements indicate a company that has seen a substantial increase in total assets and revenue over the past three years. However, it's apparent that the company is experiencing some challenges, including negative net income and cash flow issues.

Growth in Total Assets: From 2020 to 2022, the company's total assets increased from $78.66 million to $116.88 million. This growth demonstrates Neuronetics' ability to expand its asset base, which is crucial for the company's long-term financial health.

Growing Revenue: Neuronetics' total revenue increased from $49.24 million in 2020 to $65.21 million in 2022, highlighting the company's ability to generate growing sales.

Show more

Comments

Neuronetics, Inc. (NASDAQ: STIM) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Ratings data for STIM provided by MarketBeat
Show more

William Blair 
0
Report Share
14.05.24 Buy -28.94%
Prediction Buy
Perf. (%) -55.79%
Target price 7.346
Change
Ends at 06.03.25

Neuronetics, Inc. (NASDAQ: STIM) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock, up previously from $7.00.
Ratings data for STIM provided by MarketBeat
Show more

Piper Sandler 
0
Report Share
06.03.24
Prediction Buy
Perf. (%) 10.23%
Target price 6.630
Change
Ends at 08.03.24

Neuronetics, Inc. (NASDAQ: STIM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for STIM provided by MarketBeat
Show more

Canaccord Genuity Group Inc. 
0
Report Share
08.03.23
Show more
Not a member yet? Sign up for free!